Demographics. by William Toppen (3906958)

“…<div><p>Background</p><p>The role of hyperbaric oxygen therapy (HBOT) in necrotizing soft tissue infections (NSTI) is mainly based on small retrospective studies. A previous study using the 1998–2009 National Inpatient Sample (NIS) found HBOT to be associated with decreased mortality in NSTI. …”

Risk-adjusted outcomes. by William Toppen (3906958)

“…<div><p>Background</p><p>The role of hyperbaric oxygen therapy (HBOT) in necrotizing soft tissue infections (NSTI) is mainly based on small retrospective studies. A previous study using the 1998–2009 National Inpatient Sample (NIS) found HBOT to be associated with decreased mortality in NSTI. …”

The point process model predicts changes of synaptic coupling strengths due to pharmacological conditions. by Felipe Gerhard (433000)

“…All coupling strengths become weaker, that is, less inhibitory. The mean of all five existing cross-couplings (thick line) decreases significantly between the control and PTX condition. …”

Changes in depression ratings and regional glucose uptake before and after treatment. by José V. Pardo (8293983)

Summary of regression results. by Max Jordan Nguemeni Tiako (11442284)

“…</p><p>Results</p><p>The within-sex Black-White racial gap in COVID-19 incidence and mortality decreased at a similar rate among men and women but the remained wider among men. …”

S1 Raw data - by Max Jordan Nguemeni Tiako (11442284)

“…</p><p>Results</p><p>The within-sex Black-White racial gap in COVID-19 incidence and mortality decreased at a similar rate among men and women but the remained wider among men. …”

Possible scenarios explaining a changing Impact Factor (IF). by Tobias Kiesslich (292510)

“…<p>(A) Based on theoretical considerations regarding the potential influence of the variables (citations and article numbers) on the final calculation (i.e. the IF quotient), 13 scenarios are possible which either cause an increased (a1-a5), constant (b1-b3) or decreased IF (c1-c3). …”

BMT has long term effects on white adipose tissue. by Saeed Katiraei (3956147)

“…<p>(A) Weight of sWAT and vWAT pads was decreased in BMT-treated mice as compared to control mice. …”

ACKR2 contributes to pulmonary dysfunction by shaping CCL5:CCR5-dependent recruitment of lymphocytes during Influenza A infection in mice by Luciana Padua Tavares (7541546)

“…<p>Supplementary Figure 3 – Proposed mechanism: ACKR2 decreased pulmonary tolerance to influenza A virus infection by reducing CCL5 levels and impairing the development of cellular and humoral antiviral responses and tissue protection. …”

Structural imaging used to target multi-microelectrode DBS to the central lateral thalamus. by Michelle J. Redinbaugh (13029044)

Somatic cell count (SCC) of control cows and cows supplemented with <i>S</i>. <i>baicalensis</i> extract (SBE) during the first 5 d (SBE5) or 60 d (SBE60) of lactation. by K. E. Olagaray (6256859)

“…Somatic cell count was not different between SBE5 and control during wk 1–9 (<i>P</i> = 0.37) or wk 10–17 (<i>P</i> = 0.29). …”

Analyze data. by Xinhui Zhang (1624039)

“…Compared with the Sham surgery group, there was a significant decrease in NeuN over time (P < 0.01) and a significant increase in IBA-1 and CIRBP (P < 0.01) in the severe injury group. …”

Mouse spinal cord injury strike parame. by Xinhui Zhang (1624039)

“…Compared with the Sham surgery group, there was a significant decrease in NeuN over time (P < 0.01) and a significant increase in IBA-1 and CIRBP (P < 0.01) in the severe injury group. …”

Effects of vidarabine, V2E, V3E and V5E on AC activity in the heart of WT and AC5KO mice. by Kenji Suita (750993)

“…<p>(A) Vidarabine (Vida), V2E, V3E and V5E similarly and significantly decreased ISO (50 µmol/L)-stimulated AC activity in the WT heart in a dose-dependent manner. …”

Swi5 and Sfr1 have a role in HR in mammalian cells. by Yufuko Akamatsu (239815)

“…<p>(A) Swi5 interacts with Rad51 in GST pull-down assay using recombinant proteins expressed in <i>E. coli</i>. …”

Image_5_Myricetin, the Main Flavonoid in Syzygium cumini Leaf, Is a Novel Inhibitor of Platelet Thiol Isomerases PDI and ERp5.tif by Renato Simões Gaspar (8384040)

“…Additionally, myricetin is a novel inhibitor of ERp5 and PDI, unveiling a new therapeutic perspective for the treatment of thrombotic disorders.…”

Image_5_Myricetin, the Main Flavonoid in Syzygium cumini Leaf, Is a Novel Inhibitor of Platelet Thiol Isomerases PDI and ERp5.tif by Renato Simões Gaspar (8384040)

“…Additionally, myricetin is a novel inhibitor of ERp5 and PDI, unveiling a new therapeutic perspective for the treatment of thrombotic disorders.…”

Cytokine and chemokine production is impaired in the liver of infected iNOS-KO rats. by Jia Shen (1828945)

Risk of bias assessment for studies included in the systematic review using a modified version of the risk of bias criteria for interrupted time series studies, suggested by the Co... by Bruna Rubbo (287422)

Constructing the T10 spinal cord injury model. by Xinhui Zhang (1624039)